Matinas BioPharmaMTNB
MTNB
$3.77
0%
Market Cap: $18.9M
About: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Employees: 34
0
Funds holding %
of 6,710 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
14% more funds holding
Funds holding: 42 [Q1] → 48 (+6) [Q2]
3.76% more ownership
Funds ownership: 11.74% [Q1] → 15.5% (+3.76%) [Q2]
11% less capital invested
Capital invested by funds: $6.92M [Q1] → $6.15M (-$769K) [Q2]
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Research analyst outlook
We haven’t received any recent analyst ratings for MTNB.